Discontinuation report ARZERRA
| Report ID | 78219 |
| Drug Identification Number | 02381567 |
| Brand name | ARZERRA |
| Common or Proper name | ARZERRA 1000MG VIALS 50ML X 1 |
| Company Name | NOVARTIS PHARMACEUTICALS CANADA INC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | Ofatumumab |
| Strength(s) | 1000MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS |
| Packaging size | 50ML X 1 |
| ATC code | L01XC |
| ATC description | OTHER ANTINEOPLASTIC AGENTS |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | 2019-03-11 |
| Actual discontinuation date | 2019-03-11 |
| Remaining supply date | 2019-03-11 |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 700 RUE SAINT-HUBERT MONTREAL, QUEBEC CANADA H2Y 0C1 |
| Company contact information | customer.relations@novartis.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v3 | 2019-03-12 | English | Compare |
| v2 | 2019-03-11 | French | Compare |
| v1 | 2019-03-11 | English | Compare |
Showing 1 to 3 of 3